Invention Grant
US09173863B2 Antiviral compound and COX-2 inhibitor combination therapy for functional somatic syndromes, including combination of famciclovir and celecoxib
有权
功能性体细胞综合征的抗病毒化合物和COX-2抑制剂联合治疗，包括泛昔洛韦和塞来昔布组合
- Patent Title: Antiviral compound and COX-2 inhibitor combination therapy for functional somatic syndromes, including combination of famciclovir and celecoxib
- Patent Title (中): 功能性体细胞综合征的抗病毒化合物和COX-2抑制剂联合治疗，包括泛昔洛韦和塞来昔布组合
-
Application No.: US14376824Application Date: 2013-02-06
-
Publication No.: US09173863B2Publication Date: 2015-11-03
- Inventor: William L. Pridgen
- Applicant: William L. Pridgen
- Applicant Address: US AL Tuscaloosa
- Assignee: INNOVATIVE MED CONCEPTS, LLC
- Current Assignee: INNOVATIVE MED CONCEPTS, LLC
- Current Assignee Address: US AL Tuscaloosa
- Agency: Harness, Dickey & Pierce, P.L.C.
- International Application: PCT/US2013/024991 WO 20130206
- International Announcement: WO2013/119710 WO 20130815
- Main IPC: A61K31/196
- IPC: A61K31/196 ; A61K31/635 ; A61K31/52 ; A61K31/522 ; A61K31/5415 ; A61K31/415 ; A61K45/06 ; A61K31/427
Abstract:
The disclosure relates to methods of treating fibromyalgia, by administering a therapeutically-effective combination of an antiviral component and a COX-2 inhibitor component. The invention is further related to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound famciclovir and a therapeutically-effective amount of the COX-2 inhibitor celecoxib. The invention is also related to methods of treating functional somatic syndromes by administering a therapeutically-effective combination of famciclovir and celecoxib.
Public/Granted literature
Information query
IPC分类:
